121 related articles for article (PubMed ID: 2778490)
1. Sensitivity of glioma and fetal brain cell lines to natural killer cytolysis in a monolayer assay.
Kazimer RM; Whisler RL; Stephens RE; Pearl DK; Yates AJ
J Neurooncol; 1989 Jul; 7(2):145-50. PubMed ID: 2778490
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity of human glioma and brain cells to natural killer cell lysis. Effects of serum concentration, epidermal growth factor, and time in culture.
Myers RL; Whisler RL; Stephens RE; Sponseller CA; Livingston K; Spring PM; Yates AJ
J Neurosurg; 1992 Jun; 76(6):986-90. PubMed ID: 1588434
[TBL] [Abstract][Full Text] [Related]
3. Natural killer activity against cultured human neural tumor and fetal brain cells.
Yates AJ; Icard-Liepkalns C; Sirinek LP; Stephens RE; Elder PJ; Liepkalns VA; Whisler RL
Cell Immunol; 1985 Feb; 90(2):485-92. PubMed ID: 2981642
[TBL] [Abstract][Full Text] [Related]
4. Resistance to natural killer cytolysis and neutral glycolipid composition of cultured human glioma and fetal brain cells.
Yates AJ; Stephens RE; Markowitz DL; Elder PJ; Sirinek LP; Whisler RL
J Neuropathol Exp Neurol; 1985 Jul; 44(4):371-83. PubMed ID: 2409238
[TBL] [Abstract][Full Text] [Related]
5. IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression.
Zhang X; Rao A; Sette P; Deibert C; Pomerantz A; Kim WJ; Kohanbash G; Chang Y; Park Y; Engh J; Choi J; Chan T; Okada H; Lotze M; Grandi P; Amankulor N
Neuro Oncol; 2016 Oct; 18(10):1402-12. PubMed ID: 27116977
[TBL] [Abstract][Full Text] [Related]
6. Comparison of in vitro glioma cell cytotoxicity of LAK cells from glioma patients and healthy subjects.
Bosnes V; Hirschberg H
J Neurosurg; 1988 Aug; 69(2):234-8. PubMed ID: 3260622
[TBL] [Abstract][Full Text] [Related]
7. T cell-mediated cytotoxicity of human gliomas: a tumor necrosis factor-independent mechanism.
Baltuch GH; Villemure JG; McCrea E; Antel JP
Neurosurgery; 1994 Sep; 35(3):450-6; discussion 456. PubMed ID: 7800136
[TBL] [Abstract][Full Text] [Related]
8. [Changes of natural killer activity following local 60Co irradiation in intracranial tumor-bearing mice (author's transl)].
Otsuka S; Suda K; Yamashita J; Takeuchi J; Handa H
No To Shinkei; 1982 Apr; 34(4):393-8. PubMed ID: 7093076
[TBL] [Abstract][Full Text] [Related]
9. Recognition by natural killer cells of N6-isopentenyladenosine-treated human glioma cell lines.
Ciaglia E; Laezza C; Abate M; Pisanti S; Ranieri R; D'alessandro A; Picardi P; Gazzerro P; Bifulco M
Int J Cancer; 2018 Jan; 142(1):176-190. PubMed ID: 28884474
[TBL] [Abstract][Full Text] [Related]
10. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
11. In-vitro resistance of cloned human glioma cells to natural killer activity of allogeneic peripheral lymphocytes.
Zänker KS; Trappe A; Blümel G
Br J Cancer; 1982 Oct; 46(4):617-24. PubMed ID: 7138767
[TBL] [Abstract][Full Text] [Related]
12. Human tumor cell line resistance to chemotherapeutic agents does not predict resistance to natural killer or lymphokine-activated killer cell-mediated cytolysis.
Harker WG; Tom C; McGregor JR; Slade L; Samlowski WE
Cancer Res; 1990 Sep; 50(18):5931-6. PubMed ID: 1975512
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone enhances natural killer cell activity against glioma.
Shimizu K; Adachi K; Teramoto A
J Nippon Med Sch; 2005 Dec; 72(6):335-40. PubMed ID: 16415513
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cells eradicate galectin-1-deficient glioma in the absence of adaptive immunity.
Baker GJ; Chockley P; Yadav VN; Doherty R; Ritt M; Sivaramakrishnan S; Castro MG; Lowenstein PR
Cancer Res; 2014 Sep; 74(18):5079-90. PubMed ID: 25038230
[TBL] [Abstract][Full Text] [Related]
15. [Induction of cytotoxicity from human lymphocytes coated with bispecific antibody against human glioma cells].
Nitta T; Ishizawa A; Ito M; Sato K; Yagita H; Kumura K
No Shinkei Geka; 1990 Nov; 18(11):1001-6. PubMed ID: 2247192
[TBL] [Abstract][Full Text] [Related]
16. Antineoplastic effects of natural killer cells sorted with flow cytometry on brain tumors.
Kawamoto K; Fujiwara H; Numa Y; Matsumura H
Hum Cell; 1991 Jun; 4(2):157-64. PubMed ID: 1958634
[TBL] [Abstract][Full Text] [Related]
17. [The anti-tumor efficacy of lymphokine-activated killer (LAK) cells induced in vitro from peripheral blood lymphocytes of patients with malignant glioma].
Shimizu K; Miyao Y; Okamoto Y; Matsui Y; Ushio Y; Tsuda N; Hayakawa T; Ishida N; Mogami H
No To Shinkei; 1986 Mar; 38(3):265-71. PubMed ID: 3085695
[TBL] [Abstract][Full Text] [Related]
18. Natural killer susceptibility of brain tumor cell lines inversely correlates with the degree of cell differentiation and not with the level of human histocompatibility antigen expression.
Alonso C; Serrano R; Solana R; Peña J
Int Arch Allergy Appl Immunol; 1989; 89(2-3):169-72. PubMed ID: 2759715
[TBL] [Abstract][Full Text] [Related]
19. X-irradiation to human malignant glioma cells enhances the cytotoxicity of autologous killer lymphocytes under specific conditions.
Ishikawa E; Tsuboi K; Saijo K; Takano S; Ohno T
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1505-12. PubMed ID: 15275738
[TBL] [Abstract][Full Text] [Related]
20. Chemiluminescence response of human natural killer cells. I. The relationship between target cell binding, chemiluminescence, and cytolysis.
Helfand SL; Werkmeister J; Roder JC
J Exp Med; 1982 Aug; 156(2):492-505. PubMed ID: 6178787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
